US Capitol Capsule: Countdown to shutdown over Obamacare: Time to panic?
This article was originally published in Scrip
Congress has less than two weeks to either reconcile House and Senate fiscal year 2014 budget bills adopted earlier this year – a deal seen by most in Washington as highly unlikely to happen – or agree on a short-term continuing resolution (CR) before US federal agencies, like the FDA and the National Institutes of Health, are forced to shut down, resulting in delayed drug approval decisions or a slowdown in research grant awards.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.